Stock-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2012

Stock-Based Compensation Expense, Income Tax Benefits Related to Stock-Based Compensation and Excess Tax Benefits (Provision) Recorded by the Company

The following table summarizes the stock-based compensation expense (primarily in the Americas), income tax benefits related to the stock-based compensation and excess tax benefits (deficiencies) (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Stock-based compensation (expense) (1)	$	(1,250	)	$	(798	)	$	(3,111	)	$	(3,411	)
Income tax benefit (2)		438			311			1,089			1,330
Excess tax benefit (deficiency) from stock-based compensation (3)		—			(87	)		(278	)		(52	)

⁽¹⁾ Included in “General and administrative” costs in the accompanying Condensed Consolidated Statements of Operations.

⁽²⁾  Included in “Income taxes” in the accompanying Condensed Consolidated Statements of Operations.

⁽³⁾ Included in “Additional paid-in capital” in the accompanying Condensed Consolidated Statements of Changes in Shareholder’s Equity.

Summary of Assumptions Used to Estimate the Fair Value

The following table summarizes the assumptions used to estimate the fair value of SARs granted:

	Nine Months Ended September 30,
	2012			2011
Expected volatility		47.1	%		44.3	%
Weighted-average volatility		47.1	%		44.3	%
Expected dividend rate		0.0	%		0.0	%
Expected term (in years)		4.7			4.6
Risk-free rate		0.8	%		2.0	%

Summary of Stock Appreciation Rights Activity

The following table summarizes SARs activity as of September 30, 2012 and for the nine months then ended:

Stock Appreciation Rights	Shares (000s)			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (000s)
Outstanding at January 1, 2012		657		$	—
Granted		259		$	—
Exercised		—		$	—
Forfeited or expired		(51	)	$	—
Outstanding at September 30, 2012		865		$	—		7.5	$	—
Vested or expected to vest at September 30, 2012		865		$	—		7.5	$	—
Exercisable at September 30, 2012		470		$	—		6.3	$	—

Weighted Average Grant Date of the SARs Granted and Total Intrinsic Value of the SARs Exercised

The following table summarizes information regarding SARs granted and exercised (in thousands, except per SAR amounts):

	Nine Months Ended September 30,
	2012		2011
Number of SARs granted		259		215
Weighted average grant-date fair value per SAR	$	5.97	$	7.10
Intrinsic value of SARs exercised	$	—	$	—
Fair value of SARs vested	$	1,388	$	1,198

Summary of Nonvested Stock Appreciation Rights

The following table summarizes nonvested SARs activity as of September 30, 2012 and for the nine months then ended:

Nonvested Stock Appreciation Rights	Shares (000s)			Weighted Average Grant- Date Fair Value
Nonvested at January 1, 2012		362		$	7.90
Granted		259		$	5.97
Vested		(175	)	$	7.98
Forfeited or expired		(51	)	$	6.76
Nonvested at September 30, 2012		395		$	6.74

Summary of Nonvested Restricted Shares and Restricted Stock Units

The following table summarizes nonvested restricted shares/RSUs activity as of September 30, 2012 and for the nine months then ended:

Nonvested Restricted Shares and RSUs	Shares (000s)			Weighted Average Grant- Date Fair Value
Nonvested at January 1, 2012		793		$	20.39
Granted		420		$	15.21
Vested		(195	)	$	19.74
Forfeited or expired		(146	)	$	19.03
Nonvested at September 30, 2012		872		$	18.25

Summary of Weighted Average Grant-Date Fair Value Granted and Total Fair Value of Restricted Shares and Restricted Stock Units Vested

The following table summarizes information regarding restricted shares/RSUs granted and vested (in thousands, except per restricted share/RSU amounts):

	Nine Months Ended September 30,
	2012		2011
Number of restricted shares/RSUs granted		420		339
Weighted average grant-date fair value per restricted share/RSU	$	15.21	$	18.67
Fair value of restricted shares/RSUs vested	$	3,845	$	4,392

Summary of Nonvested Common Stock Units and Share Awards

The following table summarizes nonvested CSUs and share awards activity as of September 30, 2012 and for the nine months then ended:

Nonvested Common Stock Units and Share Awards	Shares (000s)			Weighted Average Grant- Date Fair Value
Nonvested at January 1, 2012		16		$	21.08
Granted		42		$	16.15
Vested		(31	)	$	17.75
Forfeited or expired		(1	)	$	21.83
Nonvested at September 30, 2012		26		$	17.18

Summary of Weighted Average Grant-Date Fair Value of the Common Stock Units and Share Awards Granted and the Total Fair Value of the Common Stock Units and Share Awards Vested

The following table summarizes information regarding CSUs/share awards granted and vested (in thousands, except per CSU/share award amounts):

	Nine Months Ended September 30,
	2012		2011
Number of CSUs/share awards granted		42		21
Weighted average grant-date fair value per CSU/share award	$	16.15	$	21.83
Fair value of CSUs/share awards vested	$	551	$	320

Summary of Nonvested Common Stock

The following table summarizes nonvested common stock activity as of September 30, 2012 and for the nine months then ended:

Nonvested Common Stock	Shares (000s)			Weighted Average Grant- Date Fair Value
Nonvested at January 1, 2012		8		$	18.30
Granted		13		$	15.28
Vested		(13	)	$	15.63
Forfeited or expired		(1	)	$	18.22
Nonvested at September 30, 2012		7		$	17.17

Summary of Weighted Average Grant-Date Fair Value of the Common Stock Awarded and Cash Used to Settle the Company's Obligation Under the Deferred Compensation

The following table summarizes information regarding shares of common stock granted and vested (in thousands, except per common stock amounts):

	Nine Months Ended September 30,
	2012		2011
Number of shares of common stock granted		13		10
Weighted average grant-date fair value per common stock	$	15.28	$	19.19
Fair value of common stock vested	$	178	$	141
Cash used to settle the obligation	$	263	$	—